Remap Consulting GmbH
Remap Consulting provides an integrated approach to pharmaceutical pricing & market access solutions.
We are a specialist pricing, reimbursement and market access consultancy offering an integrated, evidence-based approach to optimising market access. Our strength lies in our ability to understand the market access challenges from your perspective and to develop payer-focused solutions tailored to your business needs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities
Press Releases | September 22, 2025 | Medscape Education
Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...
CMI Media Group and Compas Earn 2025 Great Place To Work Certification
Press Releases | September 19, 2025 | CMI Media Group
PHILADELPHIA, PA – Strategic media healthcare agencies CMI Media Group & Compas, a WPP company (NYSE: WPP), are proud to be Certified™ by Great Place To Work® for the third year in...
solli – CMI’s International Man of Media
Press Releases | September 19, 2025 | CMI Media Group
Matt Durham, VP, Global, anticipated pharma’s global media boom. Now he’s leading CMI Media Group’s push to broaden its market coverage. This new profile article focusing on Global VP Matt...
PharmiWeb – Why Pharmaceutical Brands Must Act On Digital Trends Now
Press Releases | September 19, 2025 | CMI Media Group
The ASCO Conference has a global impact; a new PharmiWeb byline by Calum Griffin, Senior Global Engagement Planner inspired by the conference shares that the pharma marketing landscape has radically...
Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App
Press Releases | September 18, 2025 | Genetic Digital
Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.
AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation
Press Releases | September 17, 2025 | Innovative Trials
Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK
Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences
Press Releases | September 16, 2025 | Lucid Group Communications Limited
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...
Streamlining European expansion for cell and gene therapies
White Papers and Resources | September 16, 2025 | Uniphar
Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...
Current CGT landscape and future outlook
White Papers and Resources | September 16, 2025 | Uniphar
What makes CGT unique Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...
Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals
White Papers and Resources | September 16, 2025 | Uniphar
This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique scientific and logistical challenges of...